Quick Answer
IN8BIO, INC. reported Operating Income of -$19.44 million for fiscal year 2025.
IN8BIO, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$19.44M | +36.1% |
| 2024 | -$30.44M | -1.4% |
| 2023 | -$30.01M | -5.2% |
| 2022 | -$28.52M | -94.6% |
| 2021 | -$14.65M | -71.2% |
| 2020 | -$8.56M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.85M | +45.6% | +24.3% |
| June 30, 2025 | -$5.09M | +41.0% | +8.2% |
| March 31, 2025 | -$5.55M | +35.2% | +21.7% |
| September 30, 2024 | -$7.09M | +1.2% | +17.9% |
| June 30, 2024 | -$8.63M | -11.8% | -0.8% |
| March 31, 2024 | -$8.56M | -13.8% | -19.4% |
| September 30, 2023 | -$7.17M | +3.1% | +7.1% |
| June 30, 2023 | -$7.71M | -7.5% | -2.5% |
- IN8BIO, INC. showed an increase of +36.1% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, IN8BIO, INC.’s operating income has declined by 127.2% (from -$8.56 million to -$19.44 million).
- The most recent figure is from IN8BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: